Back to search results

Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes

Abroad (travel likely)Recruiting

Conditions

Aortic Valve Stenosis · Aortic Valve Insufficiency

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Hopital Estaing - Chu63 - Clermont Ferrand, Clermont-Ferrand, France

  • Institut Coeur-Poumon, CHU, Lille, France

    Study coordinator · 0320445962
    Contact: Principal Investigator (Eric VAN BELLE, MD,PhD)

  • Chu Montpellier, Montpellier, France

  • CHU de Nimes, Nîmes, France

  • Hu Pitie Salpetriere Aphp - Paris 13, Paris, France

  • Hopital Haut-Leveque - Chu - Pessac, Pessac, France

  • Chru Rennes Site Pontchaillou, Rennes, France

  • Hopital Civil / Nouvel Hopital Civil - Strasbourg, Strasbourg, France

  • CHU de Toulouse, Toulouse, France

Study leads

  • Eric Vanbelle, MD, PhD

    Principal Investigator

    University Hospital, Lille

View source on ClinicalTrials.gov(opens in a new tab)